{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T16:25:59Z","timestamp":1791217559232,"version":"4.1.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2011,5,1]],"date-time":"2011-05-01T00:00:00Z","timestamp":1304208000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Can J Public Health"],"published-print":{"date-parts":[[2011,5]]},"DOI":"10.1007\/bf03404892","type":"journal-article","created":{"date-parts":[[2019,9,12]],"date-time":"2019-09-12T16:53:24Z","timestamp":1568307204000},"page":"183-187","source":"Crossref","is-referenced-by-count":2,"title":["Effet de l\u2019implantation d\u2019une clinique de prescription m\u00e9dicale d\u2019h\u00e9ro\u00efne sur l\u2019environnement communautaire"],"prefix":"10.17269","volume":"102","author":[{"given":"Marc-Andr\u00e9","family":"Ally","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serge","family":"Brochu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c9tienne","family":"Blais","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,5,1]]},"reference":[{"issue":"3","key":"BF03404892_CR1","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1093\/eurpub\/12.3.228","volume":"12","author":"B Fischer","year":"2002","unstructured":"Fischer B, Rehm J, Kirst M, Casas M, Hall W, Krausz M, et coll. Heroinassisted treatment as a response to the public health problem of opiate dependence. Eur J Public Health 2002;12(3):228\u201334.","journal-title":"Eur J Public Health"},{"issue":"10","key":"BF03404892_CR2","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1177\/070674370605101002","volume":"51","author":"B Fischer","year":"2006","unstructured":"Fischer B, Cruz M F, Rehm J. Illicit opioid use and its key characteristics: A select overview and evidence from a Canadian multisite cohort of illicit opioid users (OPICAN). Can J Psychiatry 2006;51(10):624\u201334.","journal-title":"Can J Psychiatry"},{"key":"BF03404892_CR3","first-page":"1","volume-title":"Res Report Series","author":"National Institute on Drug Abuse.","year":"2005","unstructured":"National Institute on Drug Abuse. Heroin abuse and addiction. Res Report Series 2005;1\u20138."},{"key":"BF03404892_CR4","volume-title":"NAOMI\u2013North American Opiate Medication Initiative, pr\u00e9sent\u00e9 dans le cadre de la Tourn\u00e9e des Partenaires du RISQ","author":"P Schneeberger","year":"2007","unstructured":"Schneeberger P, Gu\u00e8vrement PA. NAOMI\u2013North American Opiate Medication Initiative, pr\u00e9sent\u00e9 dans le cadre de la Tourn\u00e9e des Partenaires du RISQ, avril 2007."},{"key":"BF03404892_CR5","doi-asserted-by":"publisher","first-page":"1496","DOI":"10.1111\/j.1360-0443.2005.01232.x","volume":"100","author":"EC Dony","year":"2005","unstructured":"Dony EC, Brasser SM, Bigelow GE, Stitzer ML, Walsh SL. Methadone doses of 100 mg or greater are more effective than lower doses at suppressing heroin self-administration in opioid-dependent volunteers. Addiction 2005;100:1496\u2013509.","journal-title":"Addiction"},{"key":"BF03404892_CR6","doi-asserted-by":"publisher","first-page":"295","DOI":"10.2466\/pr0.1998.83.1.295","volume":"83","author":"JB Murray","year":"1998","unstructured":"Murray JB. Effectiveness of methadone maintenance for heroin addiction. Psychol Rep 1998;83:295\u2013302.","journal-title":"Psychol Rep"},{"issue":"1","key":"BF03404892_CR7","doi-asserted-by":"publisher","first-page":"77","DOI":"10.2165\/00019053-200523010-00007","volume":"23","author":"AH Harris","year":"2005","unstructured":"Harris AH, Gospodarevskaya E, Ritter AJ. A randomized trial of the cost effectiveness of buprenorphine as an alternative to methadone maintenance treatment for heroin dependence in a primary care setting. Pharmacoeconomics 2005;23(1):77\u201391.","journal-title":"Pharmacoeconomics"},{"key":"BF03404892_CR8","volume-title":"Les psychotropes: pharmacologie et toxicomanie","author":"L L\u00e9onard","year":"2002","unstructured":"L\u00e9onard L, Ben Amar M. Les psychotropes: pharmacologie et toxicomanie. Montr\u00e9al, QC: Les presses de l\u2019Universit\u00e9 de Montr\u00e9al, 2002)."},{"issue":"5","key":"BF03404892_CR9","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1017\/S146114570700836X","volume":"11","author":"M Soyka","year":"2008","unstructured":"Soyka M, Zingg C, Koller G, Kuefner H. Retention rate and substance use in methadone and buprenorphine maintenance therapy and predictors of outcome: Results from a randomized study. Int J Neuropsychopharmacology 2008;11(5):641\u201353.","journal-title":"Int J Neuropsychopharmacology"},{"key":"BF03404892_CR10","doi-asserted-by":"crossref","unstructured":"Mattick RP, Kimber J. Buprenorphine maintenance versus placebo or metha-done maintenance for opioid dependence. Cochrane Database of Systematic Reviews 2003;2:CD002207.","DOI":"10.1002\/14651858.CD002207.pub2"},{"issue":"4","key":"BF03404892_CR11","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1007\/BF02247469","volume":"116","author":"EC Strain","year":"1994","unstructured":"Strain EC, Stitzer ML, Liebson IA, Bigelow GE. Buprenorphine versus metha-done in the treatment of opioid-dependent cocaine users. Psychopharmaco-logy 1994;116(4):401\u20136.","journal-title":"Psychopharmaco-logy"},{"issue":"7503","key":"BF03404892_CR12","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.1136\/bmj.330.7503.1297","volume":"330","author":"MGW Dijkgraaf","year":"2005","unstructured":"Dijkgraaf MGW, van der Zanden BP, de Borgie CA, Blanken P, van Ree JM, van den Brink W. Cost utility analysis of co-prescribed heroin compared with methadone maintenance treatment in heroin addicts in two randomised trials. Br Med J 2005;330(7503):1297\u2013303.","journal-title":"Br Med J"},{"issue":"4","key":"BF03404892_CR13","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/S0740-5472(99)00046-X","volume":"17","author":"SL Satel","year":"1999","unstructured":"Satel SL, Aeschbach E. The Swiss heroin trials. J Subst Abuse Treatment 1999;17(4):331\u201335.","journal-title":"J Subst Abuse Treatment"},{"issue":"6","key":"BF03404892_CR14","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1111\/j.1360-0443.2008.02185.x","volume":"103","author":"U Verthein","year":"2008","unstructured":"Verthein U, Bonorden-Kleij K, Degkwitz P, Dilg C, K\u00f6hler WK, Passie T, et coll. Long-term effects of heroin-assisted treatment in Germany. Addiction 2008;103(6):960\u201366.","journal-title":"Addiction"},{"key":"BF03404892_CR15","first-page":"1","volume-title":"Parliament of New South Wales, NSW, Australia","author":"A Symonds","year":"1998","unstructured":"Symonds A, Staunton PJ, Cohen I, Jobling J, Kerr M, Meagher R, et coll. Report on the Establishment or Trial of Safe Injecting Rooms 1998. Parliament of New South Wales, NSW, Australia, 1998:1\u2013294."},{"issue":"2","key":"BF03404892_CR16","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1177\/0952695102015002127","volume":"15","author":"T Dehue","year":"2002","unstructured":"Dehue T. A Dutch treat: Randomized controlled experimentation and the case of heroin-maintenance in the Netherlands. History Human Sci 2002;15(2):75\u201398.","journal-title":"History Human Sci"},{"issue":"3","key":"BF03404892_CR17","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1080\/07418829400092311","volume":"11","author":"RR Bennett","year":"1994","unstructured":"Bennett RR, Flavin JM. Determinants of fear of crime: The effect of cultural setting. Justice Q 1994;11(3):357\u201381.","journal-title":"Justice Q"},{"key":"BF03404892_CR18","volume-title":"Disorder and Decline: Crime and the Spiral of Decay in American Cities","author":"WG Skogan","year":"1990","unstructured":"Skogan WG. Disorder and Decline: Crime and the Spiral of Decay in American Cities. New York, NY: University of California Press, 1990)."},{"issue":"8","key":"BF03404892_CR19","doi-asserted-by":"publisher","first-page":"1693","DOI":"10.1016\/S0277-9536(02)00163-6","volume":"56","author":"T Pikora","year":"2003","unstructured":"Pikora T, Giles-Corti B, Bull F, Jamrozik K, Donovan R. Developing a framework for assessment of the environmental determinants of walking and cycling. Soc Sci Med 2003;56(8):1693\u2013703.","journal-title":"Soc Sci Med"},{"key":"BF03404892_CR20","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1177\/002204268501500406","volume":"14","author":"PJ Goldstein","year":"1985","unstructured":"Goldstein PJ. The drugs\/violence nexus. A tripartite conceptual framework. J Drug Issues 1985;14:493\u2013506.","journal-title":"J Drug Issues"},{"key":"BF03404892_CR21","volume-title":"Pathways to Criminal Violence","author":"JP Goldstein","year":"1989","unstructured":"Goldstein JP. Drugs and violent crime. In: Weiner NA, Wolfgang ME (\u00c9ds.). Pathways to Criminal Violence. Newbury Park, CA: Sage, 1989)."},{"key":"BF03404892_CR22","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1080\/01639620600605705","volume":"27","author":"P Manzoni","year":"2006","unstructured":"Manzoni P, Brochu S, Fischer B, Rehm J. Determinants of property crime among illicit opiate users outside of treatment across Canada. Deviant Behavior 2006;27:351\u201376.","journal-title":"Deviant Behavior"},{"key":"BF03404892_CR23","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1056\/NEJMoa0810635","volume":"361","author":"E Oviedo-Joekes","year":"2009","unstructured":"Oviedo-Joekes E, Brissette S, Marsh DC, Lauzon P, Guh D, Anis A, Schechter M. Diacetylmorphine versus methadone for the treatment of opioid addiction. N Engl J Med 2009;361:777\u201386.","journal-title":"N Engl J Med"},{"key":"BF03404892_CR24","volume-title":"Neurosciences: \u00c0 la d\u00e9couverte du cerveau","author":"MF Bear","year":"2002","unstructured":"Bear MF, Connors BW, Paradiso MA. Neurosciences: \u00c0 la d\u00e9couverte du cerveau, 2e \u00e9dition. Baltimore, MD: Lippincott Williams et Wilkins, 2002).","edition":"2e"},{"key":"BF03404892_CR25","volume-title":"Recherche et m\u00e9thodologie en sciences humaines","author":"A Lamoureux","year":"2000","unstructured":"Lamoureux A. Recherche et m\u00e9thodologie en sciences humaines, 3e \u00e9dition. Laval, QC: \u00c9ditions \u00c9tudes Vivantes, 2000).","edition":"3e"},{"key":"BF03404892_CR26","volume-title":"Experimental and Quasi-Experimental Designs for Generalized Causal Inference","author":"WR Shadish","year":"2002","unstructured":"Shadish WR, Cook TD, Campbell DT. Experimental and Quasi-Experimental Designs for Generalized Causal Inference. Boston, MA: Houghton Mifflin, 2002)."},{"key":"BF03404892_CR27","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1046\/j.1365-2710.2002.00430.x","volume":"27","author":"AK Wagner","year":"2002","unstructured":"Wagner AK, Soumerai SB, Zhang F, Ross-Degnan D. Segmented regression analysis of interrupted time series studies in medication use research. J Clin Pharm Ther 2002;27:299\u2013309.","journal-title":"J Clin Pharm Ther"},{"key":"BF03404892_CR28","volume-title":"Les violences criminelles","author":"M Ouimet","year":"1999","unstructured":"Ouimet M, Fortin F. Les voies de fait au fil des jours. Dans: Cusson M, Ouimet M, Proulx J (\u00c9ds.). Les violences criminelles. Ste-Foy, QC: Les Presses de l\u2019Universit\u00e9 Laval, 1999)."},{"key":"BF03404892_CR29","first-page":"1","volume-title":"Comit\u00e9 permanent de lutte \u00e0 la toxicomanie","author":"P Brisson","year":"1997","unstructured":"Brisson P. L\u2019approche de r\u00e9duction des m\u00e9faits: sources, situation, pratiques. Comit\u00e9 permanent de lutte \u00e0 la toxicomanie, Montr\u00e9al, QC: Gouvernement du Qu\u00e9bec, 1997):1\u2013127."},{"issue":"1","key":"BF03404892_CR30","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.drugpo.2009.04.003","volume":"21","author":"B Lasnier","year":"2010","unstructured":"Lasnier B, Brochu S, Boyd N, Fischer B. A heroin prescription trial: Case studies from Montreal and Vancouver on crime and disorder in the surrounding neighbourhoods. Int J Drug Pol 2010;21(1):28\u201335.","journal-title":"Int J Drug Pol"}],"container-title":["Canadian Journal of Public Health"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF03404892.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF03404892\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF03404892.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,13]],"date-time":"2019-09-13T12:46:21Z","timestamp":1568378781000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF03404892"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,5]]},"references-count":30,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2011,5]]}},"alternative-id":["BF03404892"],"URL":"https:\/\/doi.org\/10.1007\/bf03404892","relation":{},"ISSN":["0008-4263","1920-7476"],"issn-type":[{"value":"0008-4263","type":"print"},{"value":"1920-7476","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,5]]}}}